HER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series-Reference-Cited by-同舟云学术

HER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series

Published:2013-01-24 Issue:2 Volume:14 Page:2370-2387
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Aprile Giuseppe,De Maglio Giovanna,Menis Jessica,Casagrande Mariaelena,Tuniz Francesco,Pisa Edith,Fontanella Caterina,Skrap Miran,Beltrami Alberto,Fasola Gianpiero,Pizzolitto Stefano

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/14/2/2370/pdf

Reference61 articles.

1. Brain metastases from gastrointestinal tumours: Tailoring the approach to maximize the outcome;Menis;Crit. Rev. Oncol. Hematol,2013

2. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy;Kopetz;J. Clin. Oncol,2009

3. The incidence and outcome of brain metastases after liver resection for colorectal cancer metastases;Byrne;Colorectal. Dis,2012

4. Treatment of metastatic colorectal cancer;Davies;Semin. Oncol,2011

5. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: A multifactorial model of 929 patients;Rees;Ann. Surg,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives;Critical Reviews in Oncology/Hematology;2023-06

2. Erythroblastic oncogene B-2 status and intracranial metastatic disease in patients with gastrointestinal cancer: a systematic review;Journal of Neuro-Oncology;2022-11-13

3. Precision Medicine in Metastatic Colorectal Cancer: Targeting ERBB2 (HER-2) Oncogene;Cancers;2022-07-30

4. Mind the target: human epidermal growth factor receptor 2 in colorectal cancer;Current Opinion in Oncology;2022-06-22

5. Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy;Biomedicines;2022-04-30